How cosmetic science is revolutionizing eczema treatment at NYSCC 2025 

Eczema is a widespread inflammatory skin condition affecting millions globally. Characterized by persistent itching, redness, and a compromised skin barrier, it significantly impacts the quality of life of an increasing set of individuals worldwide. 

While not all forms of eczema are chronic, certain types, most notably atopic dermatitis, are characterized by their long-term, relapsing nature. Understanding this distinction is key to appreciating the evolving landscape of eczema treatments, which are increasingly focused on managing chronic conditions and preventing flare-ups.  

NYSCC 2025 emerged as a pivotal platform, showcasing how advanced natural cosmetic ingredients are revolutionizing eczema treatment, moving beyond mere aesthetics to deliver scientifically validated, performance-driven solutions. This revolution is fundamentally transforming the approach to sensitive skin care, emphasizing both efficacy and safety. 

What is eczema? 

Understanding eczema requires a comprehensive perspective that transcends superficial symptoms. Eczema is a complex, inflammatory skin condition rooted in a dysfunctional skin barrier, immune dysregulation, and often an imbalance in the skin microbiome. Individuals with eczema frequently experience intense itching, persistent redness, and dry skin, leading to visible eczema flares that can be both physically uncomfortable and emotionally distressing.  

Beyond genetic predisposition, understanding what does eczema look like at a deeper biological level reveals that factors such as environmental aggressors, psychological stress, and specific microbial imbalances on the skin significantly contribute to its onset and severity (Kim et al., 2019). 

Types of eczema and their relationship to chronicity 

 To fully grasp the multifaceted nature of eczema, it’s essential to differentiate its various types and understand their typical course: 

• Atopic dermatitis (AD): This is the most common and often the most well-known type of eczema, particularly in discussions of chronicity. AD is a chronic inflammatory skin condition, frequently starting in childhood, that is linked to a predisposition to developing allergic diseases (atopy). It is characterized by periods of remission and exacerbation (flares) throughout a person’s life. The underlying mechanisms involve a compromised skin barrier and an overactive immune response. 
   

• Contact dermatitis: This type of eczema occurs when the skin comes into contact with an irritant (irritant contact dermatitis) or an allergen (allergic contact dermatitis). While the individual episodes can be acute, repeated exposure to the trigger can lead to chronic inflammation. However, unlike atopic dermatitis, it’s not inherently a chronic condition if the trigger is identified and avoided. 
   

• Dyshidrotic eczema (Pompholyx): Characterized by small, itchy blisters on the palms, soles, and sides of the fingers and toes. This type can be chronic and recurrent, often triggered by stress, sweat, or contact with certain metals. Its chronicity varies greatly among individuals. 
   

• Nummular eczema (discoid eczema): Presents as coin-shaped patches of irritated skin. While it can resolve, it often has a chronic and relapsing course, especially in older adults. 
   

• Seborrheic dermatitis: This type of eczema commonly affects areas rich in oil glands, like the scalp, face, and chest. It’s typically a chronic condition, with periods of improvement and worsening, but it’s generally manageable with ongoing treatment. 
   

• Stasis dermatitis: Occurs in individuals with poor circulation, typically in the lower legs. It’s a chronic condition due to the underlying circulatory issues, and management focuses on both skin symptoms and improving blood flow. 

While ‘eczema’ encompasses a range of conditions, the term ‘chronic eczema’ most frequently refers to atopic dermatitis due to its inherent long-term nature. Other types can become chronic if triggers are not avoided or underlying conditions persist, but their primary characteristic isn’t necessarily lifelong recurrence in the same way as atopic dermatitis. 

How does cosmetic science play a role in eczema treatment? 

The limitations of conventional treatments often necessitate a more nuanced approach. While traditional topical corticosteroids and immunomodulators can provide temporary relief from inflammation and itching, they may not address the underlying type of eczema or its multifactorial triggers, and their long-term use can sometimes lead to undesirable side effects. This unmet need has spurred cosmetic science to play a more profound role.  

Moving beyond just aesthetics, modern cosmetic science is now at the forefront of developing sophisticated solutions that directly target the underlying causes of eczema, aiming not merely for symptomatic relief but for true skin health restoration. This involves a rigorous focus on reducing inflammation, strengthening the skin’s protective barrier, and modulating the skin’s delicate ecosystem to prevent future flares and promote lasting comfort for people with chronic eczema. 

Advances in eczema treatment at NYSCC 2025 

Awareness and reported experience of skin conditions, including eczema, has risen notably in the United States. According to Mintel consumer surveys, the percentage of US adults who reported experiencing any skin condition in the past 12 months increased from 68% in 2022 to 78% in 2024. Eczema is among the most common conditions, especially among younger consumers. For example, in 2024, 23% of men aged 18-34 and 24% of men aged 35-54 reported experiencing eczema in the past year. Additionally, the share of baby personal care products in the US with skin disorder claims (mostly related to eczema) more than doubled from 2019 to 2022, reflecting increased consumer demand and awareness. 

NYSCC 2025 therefore marked a definitive shift in the beauty industry’s approach to skin condition care, particularly in the realm of eczema treatment. The event highlighted a profound transformation in how formulators and R&D professionals view and address chronic skin sensitivities. The traditional emphasis on generic “natural” and “sustainability” rhetoric has matured into a rigorous pursuit of “innovation,” “plant-based performance,” and “clean beauty“, all underpinned by rigorous scientific validation. This evolution sets a new benchmark for efficacy and transparency in the cosmetic sector. 

Emerging fields such as neurocosmetics and microbiome science were prominently featured as critical frontiers for research and development. These areas recognize the intricate connections between the nervous system, the skin’s microbial inhabitants, and inflammatory responses—factors that significantly influence eczema pathology. 

The discussions at NYSCC Suppliers’ Day underscored that for an ingredient to hold significant value in today’s market, it must not only be naturally derived but also scientifically proven to deliver superior, demonstrable performance. This evolution raises the bar for R&D, demanding a deeper understanding of biological mechanisms and robust clinical evidence. 

New cosmetic formulations for sensitive skin care 

The landscape of new cosmetic formulations for eczema treatment is characterized by increasingly sophisticated, multi-targeted strategies. These advanced formulations are designed to address the various facets of eczema pathology simultaneously, moving beyond singular solutions to offer comprehensive relief and prevention.  

Modern approaches focus on direct anti-inflammatory actions, comprehensive barrier repair, and precise microbial balance, alongside novel neuro-immune modulation techniques. This holistic strategy recognizes the complex interplay of factors contributing to different kinds of eczema, aiming to restore skin homeostasis. 

 
How cosmetic science is addressing eczema flares and sensitive skin 

Cosmetic science is making significant strides in both the prevention and management of eczema flares and the overall care of sensitive skin. The focus has expanded beyond simply treating symptoms during a flare-up to proactively building the skin’s inherent resilience against triggers. This involves developing ingredients that reduce immediate discomfort, such as itching and burning sensations, while simultaneously strengthening the skin’s natural defenses. 

By understanding the cascade of events that leads to an eczema flare—from initial trigger exposure to subsequent inflammation and barrier disruption—cosmetic innovations are designed to interrupt this cycle. This proactive approach aims to make reactive skin more resistant to inflammation and to prevent secondary infections that can often complicate eczema. The emphasis is on continuous, gentle care for sensitive skin, shifting the paradigm from crisis management to long-term health maintenance, providing people with eczema a greater sense of comfort and control over their condition. 

Natural remedies for eczema: Integrating nature with cosmetic innovation 

The increasing demand for natural remedies for eczema is not merely a passing trend but a testament to a scientifically driven movement in cosmetic science. The value proposition of natural, plant-based ingredients has profoundly shifted, now being defined by their proven performance rather than just their origin. This new era sees the seamless integration of traditional botanical knowledge with cutting-edge scientific validation, offering powerful and effective alternatives to synthetic compounds. 

These advanced natural ingredients provide solutions that are not only effective in treating eczema symptoms but also align with the growing consumer preference for “clean beauty” and products perceived to have fewer side effects. Furthermore, the commitment to sustainability and ethical sourcing practices for these natural ingredients adds another critical layer of value.  

This extends beyond simple “natural” claims to encompass the entire lifecycle of the ingredient, from responsible cultivation to biotechnological production methods that ensure consistent, high-purity supply while minimizing environmental impact. For formulators, embracing these innovative, scientifically validated natural ingredients allows for the creation of high-performance, safe, and highly marketable products that genuinely enhance the well-being of people with eczema. 

Innovations and ingredients for eczema and sensitive skin care 

The cosmetic industry, Provital in particular, is currently experiencing a surge in cutting-edge, natural ingredients that are backed by rigorous scientific validation, transforming the landscape of eczema treatment. These innovations exemplify the industry’s commitment to delivering high-performance, nature-derived solutions for compromised and reactive skin. 

Senseryn™: Back to calm through your senses 

Senseryn™, derived from Humulus lupulus (Hops) extract, represents a novel approach to calming sensitive and reactive skin. Its unique mechanism of action involves the activation of sensory bitter taste receptors (T2Rs) present in skin cells, which has been scientifically shown to initiate a calming cascade. This innovative pathway offers a new strategy for soothing discomfort and reducing irritation. 

Beyond its calming effects, Senseryn™ contributes significantly to skin barrier enhancement and protection. It boosts the production of β-defensin 3, enhancing the skin’s innate immunity and offering crucial infection protection. Furthermore, it improves dermal structure by supporting the synthesis of Collagen-I and SERPINH1. A critical aspect for people with eczema is its ability to optimize the anti-dermatitis microbiota, notably improving the ratio of beneficial Staphylococcus epidermidis to pathogenic Staphylococcus aureus, thereby helping to prevent superinfection and reduce inflammatory sequelae.  

In in vivo studies, Senseryn™ demonstrated a 21% reduction in itching and a 12% decrease in redness number for atopic-prone skin after 28 days of use. These multifaceted benefits underscore Senseryn’s™ role in improving the quality of life for individuals with reactive skin by addressing both sensory discomfort and underlying microbial imbalance. 

Agascalm™: Reduces stress-induced skin inflammation and redness 

Agascalm™, an innovative ingredient sourced from Agastache mexicana extract, specifically targets the intricate mind-skin connection, a critical yet often overlooked factor in eczema. In today’s demanding society, psychological stress is a pervasive trigger for skin inflammation and exacerbates eczema flares. Agascalm™ is designed to neutralize the negative effects of this stress on the skin. 

Its mechanism involves inhibiting key pro-inflammatory mediators such as Interleukin-1α (IL-1α), IL-6, IL-8, and Tumor Necrosis Factor-alpha (TNF-α), while also reducing prostaglandin E2 (PGE2) synthesis. Furthermore, Agascalm™ has been shown to decrease cortisol levels within the skin, directly mitigating the biological impact of stress.  

Through these actions, Agascalm™ effectively prevents and delays inflammatory reactions, neutralizes the burning sensation often associated with eczema flares, and restores overall skin comfort. By addressing the neuro-psychological link and stress-induced flares, Agascalm™ offers a vital component in comprehensive eczema treatment. In vivo studies showed a 30% reduction in Cutaneous Microvascular Blood Flow (CMBC) and a 25% reduction in Laser Doppler Flow (LDF), indicating decreased vasodilation. 

Dermasooth™: A truly soothing solution 

Dermasooth™ is a powerful blend of natural ingredients specifically designed to protect and soothe sensitive skin from external aggressions that can trigger or worsen eczema. It combines extracts from Tulsi (Ocimum tenuiflorum L.), Lady’s Thistle (Silybum marianum (L.) Gaertner), and active fractions of Enteromorpha compressa (green algae). 

This synergistic complex works by reducing inflammatory mediators such as IL-6, IL-8, and PGE2, and inhibiting COX-2, which are crucial in the inflammatory cascade. Dermasooth™ provides robust protection against inflammation induced by various external factors, including mechanical stress (e.g., shaving, epilation, chafing) and pollution. These common irritants can severely compromise the already fragile skin barrier of individuals with eczema.  

Through its multifaceted action, Dermasooth™ soothes irritation, significantly reduces redness, and improves the skin barrier function. For example, it demonstrated a 40% inhibition of PGE2 synthesis in fibroblasts and 61% in keratinocytes, alongside significant reductions in IL-6 and IL-8 production. It helps the skin recover faster from aggressions, making it an essential ingredient for protecting compromised skin from environmental and mechanical triggers, and an excellent solution for various types of eczema exacerbated by everyday stressors. 

How NYSCC 2025 is driving innovation in skin condition care 

NYSCC 2025 served as a crucial nexus for showcasing groundbreaking research, fostering collaboration, and accelerating product development in sensitive skin and eczema treatment.  

The event highlighted the industry’s collective commitment to advancing scientific understanding and creating more effective solutions for chronic skin conditions. It highlighted the importance of an interdisciplinary approach, bringing together experts in chemistry, biology, dermatology, and formulation science. 

The future outlook, as illuminated at NYSCC Suppliers Day, is one where eczema treatment is increasingly personalized, leveraging advanced delivery systems and comprehensive ingredient synergies to address individual patient needs. Continuous research into the complex interplay of the skin barrier, microbiome, and neuro-immune system will drive further breakthroughs. The innovations presented at NYSCC 2025 underscore that the future of sensitive skin care and eczema lies in sophisticated, scientifically validated natural cosmetic ingredients that aim for holistic skin health. 

For further information or insights on cosmetic innovation, please do not hesitate to contact our team of experts, who are available to provide guidance and support in selecting the most suitable solutions for your requirements.